Twist Bioscience

(NASDAQ) TWST

Current Price$53.91

Market Cap$3.34B

Since IPO (2018)+283%

5 Year-44%

1 Year+74%

1 Month-13%

Twist Bioscience Financials at a Glance

Market Cap

$3.34B

Revenue (TTM)

$409.48M

Net Income (TTM)

$81.28M

EPS (TTM)

$-1.33

P/E Ratio

-40.39

Dividend

$0.00

Beta (Volatility)

2.34 (High)

Dividend

$0.00

Beta (Volatility)

2.34 (High)

Price

$53.91

Volume

339,421.513

Open

$52.61

Price

$53.91

Volume

339,421.513

Open

$52.61

Previous Close

$53.66

Daily Range

$51.80 - $54.08

52-Week Range

$23.30 - $66.06

Dividend

$0.00

Beta (Volatility)

2.34 (High)

Price

$53.91

Volume

339,421.513

Open

$52.61

Previous Close

$53.66

Daily Range

$51.80 - $54.08

52-Week Range

$23.30 - $66.06

TWST News

A scientist looking through a microscope.

Page 1

TWST: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Twist Bioscience

Industry

Biotechnology

Sector

Health Care

Employees

979

CEO

Emily Marine Leproust, PhD

Website

www.twistbioscience.com

Headquarters

South San Francisco, CA 94080, US

TWST Financials

Key Financial Metrics (TTM)

Gross Margin

52%

Operating Margin

-34%

Net Income Margin

-20%

Return on Equity

-18%

Return on Capital

-25%

Return on Assets

-12%

Earnings Yield

-2.48%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.34B

Shares Outstanding

62.27M

Volume

339.42K

Avg. Volume

1.24M

Financials (TTM)

Gross Profit

$191.00M

Operating Income

$136.26M

EBITDA

$52.10M

Operating Cash Flow

$47.63M

Capital Expenditure

$28.00M

Free Cash Flow

$75.63M

Cash & ST Invst.

$232.43M

Total Debt

$137.32M

Twist Bioscience Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$110.72M

+19.3%

Gross Profit

$57.12M

+24.1%

Gross Margin

51.59%

N/A

Market Cap

$3.34B

N/A

Market Cap/Employee

$3.62M

N/A

Employees

923

N/A

Net Income

$44.02M

-11.9%

EBITDA

$39.67M

-21.7%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$75.83M

-57.1%

Accounts Receivable

$64.15M

+28.4%

Inventory

$33.52M

+60.7%

Long Term Debt

$85.40M

+31.2%

Short Term Debt

$10.44M

-31.4%

Return on Assets

-12.02%

N/A

Return on Invested Capital

-24.96%

N/A

Free Cash Flow

$25.55M

-49.1%

Operating Cash Flow

$17.56M

-35.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EWTXEdgewise Therapeutics, Inc.

EWTXEdgewise Therapeutics, Inc.$32.76-0.18%

GRDNGuardian Pharmacy Services, Inc.

GRDNGuardian Pharmacy Services, Inc.$37.59-0.11%

GPCRStructure Therapeutics Inc.

GPCRStructure Therapeutics Inc.$38.02+3.12%

MESOMesoblast Limited

MESOMesoblast Limited$14.89+2.55%

CLOVClover Health Investments, Corp.

CLOVClover Health Investments, Corp.$3.60+0.42%

PRCTPROCEPT BioRobotics Corporation

PRCTPROCEPT BioRobotics Corporation$28.85+2.63%

VRDNViridian Therapeutics, Inc.

VRDNViridian Therapeutics, Inc.$17.71+0.44%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.74+0.00%

TET1 Energy Inc.

TET1 Energy Inc.$9.20+0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.69-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.66+0.01%

RGTZTidal Trust II - Defiance Daily Target 2x Short Rgti ETF

RGTZTidal Trust II - Defiance Daily Target 2x Short Rgti ETF$6.05-0.51%

APLDApplied Digital

APLDApplied Digital$47.17+0.19%

RGTIRigetti Computing

RGTIRigetti Computing$21.35+0.26%

Questions About TWST

What is the current price of Twist Bioscience?

Twist Bioscience is trading at $53.92 per share.

What is the 52-week range for Twist Bioscience?

Over the past 52 weeks, Twist Bioscience has traded between $23.30 and $66.06.

How much debt does Twist Bioscience have?

As of the most recent reporting period, Twist Bioscience reported total debt of $95.84M.

How much cash does Twist Bioscience have on hand?

Twist Bioscience reported $122.67M in cash and cash equivalents in its most recent financial results.

What is Twist Bioscience’s dividend yield?

Twist Bioscience does not currently have a dividend yield.

Twist Bioscience

Twist Bioscience Financials at a Glance

TWST News

Best Biotech ETFs to Buy in 2026

Twist Bioscience (TWST) Q3 Profit Surges

Why Shares of Twist Bioscience Are Up Friday

2 Cathie Wood Growth Stocks That Could Make You Richer

3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers

Why Twist Bioscience Stock Is Sinking Today

Why Twist Bioscience Stock Is Crashing This Week

Why Shares of Twist Bioscience Fell 19.92% on Tuesday

TWST: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Twist Bioscience

TWST Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Twist Bioscience Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TWST

What is the current price of Twist Bioscience?

What is the 52-week range for Twist Bioscience?

How much debt does Twist Bioscience have?

How much cash does Twist Bioscience have on hand?

What is Twist Bioscience’s dividend yield?

Premium Investing Services